Bobba Venkatadri, president and COO of ultrasound contrast vendor Molecular Biosystems, will add CEO to his list of titles. MBI's previous CEO and founder, Dr. Kenneth Widder, will remain chairman and continue to be responsible for strategic planning and
Bobba Venkatadri, president and COO of ultrasound contrast vendor Molecular Biosystems, will add CEO to his list of titles. MBI's previous CEO and founder, Dr. Kenneth Widder, will remain chairman and continue to be responsible for strategic planning and corporate development activities. Venkatadri's promotion culminated a succession plan agreed upon when he was hired in November 1995, according to the San Diego-based company.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.